Impact of Iron Supplementation During Pregnancy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorJohann Wolfgang Goethe University Hospital
About this trial
During pregnancy, iron deficiency is the most common cause of anemia. Anemia is very common during pregnancy and after childbirth. Around half of pregnant women develop anemia, and after delivery, up to 85% of women may be affected.
This study looks at whether iron given through a vein (intravenous iron) can improve blood levels and how women feel and function in everyday life before and after giving birth.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pregnancy
Disqualifiers
Thalassemia
Sickle cell disease
Aplastic anemia
Hemochromatosis
Trial population
anemia walk-in clinic
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Iron
DrugIron supplementation will be performed according to Hamza et al., Recommendations of the AGG (Obstetrics Working Group, Section for Maternal Diseases) for the Management of Anemia in Pregnancy - Part 1 (Iron Deficiency Anemia) (https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-2628-7308.pdf)
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Proportion of patients achieving an increase in hemoglobin concentration of ≥1 g/dL
Proportion of patients with an increase in hemoglobin concentration of ≥1 g/dL from before the first intravenous iron administration to the last available measurement before delivery
Time frame
between iron supplementation and follow-up: 2-4 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Johann Wolfgang Goethe University Hospital
Lead sponsor
Wuerzburg University Hospital
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: